These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 28302662)

  • 1. Therapeutic challenge of a paediatric case of Graves' disease with severe ophthalmopathy.
    Ferreira C; Meireles C; Marques O; Antunes A
    BMJ Case Rep; 2017 Mar; 2017():. PubMed ID: 28302662
    [No Abstract]   [Full Text] [Related]  

  • 2. Total thyroidectomy (Tx) versus thionamides (antithyroid drugs) in patients with moderate-to-severe Graves' ophthalmopathy - a 1-year follow-up: study protocol for a randomized controlled trial.
    Brammen L; Riss P; Lukas J; Gessl A; Dunkler D; Li S; Leisser A; Rezar-Dreindl S; Eibenberger K; Selberherr A; Scheuba C; Papp A
    Trials; 2018 Sep; 19(1):495. PubMed ID: 30219088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Management of Graves' orbitopathy. Comments on the EUGOGO consensus statement].
    Bednarczuk T; Bar-Andziak E; Hubalewska-Dydejczyk A; Waligórska A; Górska M; Myśliwiec J; Jarzab B; Karczmarzyk R; Zawadzka A; Garmol D; Kecik D; Królicki L; Plazińska MT; Krzeski A; Krzyzanowska-Swiniarska B; Lewiński A; Milewicz A; Daroszewski J; Placzkiewicz-Jankowska E; Pilarska K; Skórski M; Wiechno W; Sowiński J; Syrenicz A; Szafilk J; Wanyura H; Zgliczński W; Jastrzebska H; Nauman J
    Endokrynol Pol; 2009; 60(4):312-30. PubMed ID: 19753546
    [No Abstract]   [Full Text] [Related]  

  • 4. Graves' Disease.
    Smith TJ; Hegedüs L
    N Engl J Med; 2016 Oct; 375(16):1552-1565. PubMed ID: 27797318
    [No Abstract]   [Full Text] [Related]  

  • 5. [Update on endocrine orbitopathy].
    Ponto KA; Kahaly GJ; Pitz S
    Klin Monbl Augenheilkd; 2009 Feb; 226(2):R13-28; quiz R29-31. PubMed ID: 19206039
    [No Abstract]   [Full Text] [Related]  

  • 6. Current and Future Treatments for Graves' Disease and Graves' Ophthalmopathy.
    Kotwal A; Stan M
    Horm Metab Res; 2018 Dec; 50(12):871-886. PubMed ID: 30286486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment-resistant severe, active Graves' ophthalmopathy successfully treated with B lymphocyte depletion.
    El Fassi D; Nielsen CH; Hasselbalch HC; Hegedüs L
    Thyroid; 2006 Jul; 16(7):709-10. PubMed ID: 16889501
    [No Abstract]   [Full Text] [Related]  

  • 8. [A special case of thyroid associated ophthalmopathy in the course of Graves-Basedow disease].
    Bałdys-Waligórska A; Kuśnierz-Cabala B; Huszno B
    Endokrynol Pol; 2006; 57(5):536-40. PubMed ID: 17133319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superior ophthalmic vein thrombosis: A rare complication of Graves' orbitopathy.
    Sorrentino D; Taubenslag KJ; Bodily LM; Duncan K; Stefko T; Yu JY
    Orbit; 2018 Jun; 37(3):175-178. PubMed ID: 29053044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Current management of endocrine orbitopathy].
    Ponto KA; Kahaly GJ
    Med Klin (Munich); 2008 Oct; 103(10):717-30; quiz 729-30. PubMed ID: 18936897
    [No Abstract]   [Full Text] [Related]  

  • 11. A treatment strategy for Graves' orbitopathy.
    Marcocci C; Pinchera A; Marinò M
    Nat Clin Pract Endocrinol Metab; 2007 May; 3(5):430-6. PubMed ID: 17452970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraorbital Electroacupuncture Therapy for Thyroid-associated Ophthalmopathy.
    Zhou LY; Su C; Li XM; Liu TJ; Zhao M
    Chin Med J (Engl); 2017 Aug; 130(15):1884-1885. PubMed ID: 28748866
    [No Abstract]   [Full Text] [Related]  

  • 13. Relationship between Graves' ophthalmopathy and type of treatment of Graves' hyperthyroidism.
    Marcocci C; Bartalena L; Bogazzi F; Bruno-Bossio G; Pinchera A
    Thyroid; 1992; 2(2):171-8. PubMed ID: 1525588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Corticosteroids and radiotherapy in the treatment of Graves' ophthalmopathy].
    Nasr E; Khater S; Nehme-Nasr D; Azoury F; Jambart S
    J Med Liban; 2010; 58(2):86-90. PubMed ID: 20549894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe eyelid oedema in Graves' ophthalmopathy.
    Anagnostis P; Adamidou F; Poulasouchidou M; Karras S
    BMJ Case Rep; 2013 Jul; 2013():. PubMed ID: 23853193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of Graves' ophthalmopathy.
    Wiersinga WM
    Nat Clin Pract Endocrinol Metab; 2007 May; 3(5):396-404. PubMed ID: 17452966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of abnormal thyroid function on the severity of Graves' ophthalmopathy.
    Prummel MF; Wiersinga WM; Mourits MP; Koornneef L; Berghout A; van der Gaag R
    Arch Intern Med; 1990 May; 150(5):1098-101. PubMed ID: 1691908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The blinding thyroid gland.
    Lam L; Stack R
    Orbit; 2018 Oct; 37(5):393-394. PubMed ID: 29341792
    [No Abstract]   [Full Text] [Related]  

  • 19. Patients with severe Graves' ophthalmopathy have a higher risk of relapsing hyperthyroidism and are unlikely to remain in remission.
    Eckstein AK; Lax H; Lösch C; Glowacka D; Plicht M; Mann K; Esser J; Morgenthaler NG
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):607-12. PubMed ID: 17880407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of the effectiveness of 131-I and antithyroid drugs in the treatment of Graves' disease in children].
    Chen DY; Chen TH
    Zhonghua Er Ke Za Zhi; 2005 Jul; 43(7):507-9. PubMed ID: 16083551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.